GOSS

NASDAQStock

Gossamer Bio, Inc.

$0.45-0.01 (-1.61%)

52-Week Range

$0.38
$3.79

Key Stats

Market Cap

104.8M

P/E Ratio

Dividend Yield

Beta

2.11

Volume

4.5M

Avg Volume

39.2M

Performance

1M

-80.17%

3M

-87.86%

6M

-85.53%

YTD

-84.03%

1Y

-68.28%

3Y

-65.15%

5Y

-95.66%

Price Chart

ETF Exposure

GOSS is held by 62 ETFs

ETFFund NameWeight
IWViShares Russell 3000 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
PreviousPage 2 of 2

About GOSS ETF Exposure

Gossamer Bio, Inc. (GOSS) is held by 62 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 104.8M, GOSS is a widely held institutional stock. The stock currently trades at $0.45. Investors can gain exposure to GOSS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold GOSS, sorted by portfolio weight.